Arvelle to Present at Jefferies 2019 London Healthcare Conference

Zug, Switzerland, November 15, 2019 - Arvelle Therapeutics GmbH (Arvelle), an emerging biopharmaceutical company focused on bringing innovative treatments to patients suffering from CNS disorders, today announces that Mark Altmeyer, President and Chief Executive Officer of Arvelle, will present at the Jefferies 2019 London Healthcare Conference on Wednesday, 20 November 2019 at 2:40 p.m. GMT.